NCT01113281: Dose-Escalation Study on Safety and Immunogenicity of VPM1002 in Comparison to BCG in Healthy Volunteers in South Africa |
|
|
| Completed | 1 | 24 | RoW | VPM1002 live vaccine, commercially available live vaccine BCG | Vakzine Projekt Management GmbH, Farmovs-Parexel Bloemfontein, Republic of South Africa (Clinical Site), Triclinium Johannesburg, RSA (Monitoring and Overall Management of the study), University of Stellenbosch, HJ-CTC George, RSA (Statistics & Report) | Tuberculosis | 12/10 | 03/11 | | |
